New Key Statistics Module, Z-Score and F-Score
NAS:CDTX Key Ratios
| Market Cap $ M | 57.07 |
| Enterprise Value $ M | 26.17 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.92 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 63.00 |
| EPS (TTM) $ | -5.20 |
| Beneish M-Score | -0.64 |
| 10-y EBITDA Growth Rate % | 8.20 |
| 5-y EBITDA Growth Rate % | 34.40 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.07 |
| EV-to-EBITDA | -1.09 |
| PEG | -- |
| Shares Outstanding M | 4.56 |
| Net Margin (%) | -35.88 |
| Operating Margin % | -38.31 |
| Pre-tax Margin (%) | -35.19 |
| Quick Ratio | 0.81 |
| Current Ratio | 0.90 |
| ROA % (ttm) | -34.99 |
| ROE % (ttm) | -414.80 |
| ROIC % (ttm) | -91.25 |
| Dividend Yield % | -- |
| Altman Z-Score | -9.04 |
CDTX Number of Guru Trades
CDTX Volume of Guru Trades
Gurus Latest Trades with NAS:CDTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CDTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Cidara Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CDTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers